Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2014-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2013070773PMID 24511119PMCID PMC4073433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

  2013cited by this paper
• Predictors of response to targeted therapy in renal cell carcinoma.

  2012cited by this paper
• A novel radioresistant mechanism of galectin-1 mediated by H-Ras-dependent pathways in cervical cancer cells

  2012cited by this paper
• Quantitative Proteomic Analysis in Metastatic Renal Cell Carcinoma Reveals a Unique Set of Proteins with Potential Prognostic Significance*

  2012cited by this paper
• Metastatic Renal Cell Carcinoma: The Importance of Immunohistochemistry in Differential Diagnosis

  2012cited by this paper
• Emerging immunotherapies for renal cell carcinoma.

  2012cited by this paper
• Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2

  2012cited by this paper
• Inhibiting galectin-1 reduces murine lung metastasis with increased CD4+ and CD8+ T cells and reduced cancer cell adherence

  2012cited by this paper
• High expression of CXCR4, CXCR7 and SDF-1 predicts poor survival in renal cell carcinoma

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Strategies for H-score Normalization of Preanalytical Technical Variables with Potential Utility to Immunohistochemical-Based Biomarker Quantitation in Therapeutic Reponse Diagnostics

  2011cited by this paper
• Targeting Galectin-1 in Carcinoma-Associated Fibroblasts Inhibits Oral Squamous Cell Carcinoma Metastasis by Downregulating MCP-1/CCL2 Expression

  2011cited by this paper
• CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy

  2010cited by this paper
• VHL and HIF signalling in renal cell carcinogenesis

  2010cited by this paper
• Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells.

  2010cited by this paper
• Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1.

  2010cited by this paper
• Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis

  2009cited by this paper
• Galectins: structure, function and therapeutic potential

  2008cited by this paper
• Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Whole cell profiling and identification of galectin‐1 as a potential marker of renal cell carcinoma

  2007cited by this paper
• Chemokines: novel targets for breast cancer metastasis

  2007cited by this paper
• Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.

  2007cited by this paper
• The regulatory roles of cell surface sialylation and N-glycans in human B cell lymphoma cell adhesion to galectin-1.

  2006cited by this paper
• Galectin-1: a small protein with major functions.

  2006cited by this paper
• Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

  2006cited by this paper
• The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.

  2005cited by this paper
• Prognostic Significance of Endogenous Adhesion/Growth-Regulatory Lectins in Lung Cancer

  2005cited by this paper
• Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages.

  2005cited by this paper
• Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.

  2005cited by this paper
• Transforming growth factor‐β1 increases CXCR4 expression, stromal‐derived factor‐1α‐stimulated signalling and human immunodeficiency virus‐1 entry in human monocyte‐derived macrophages

  2005cited by this paper
• Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1α*

  2005cited by this paper
• TNF α‐induced ras activation due to ethanol promotes hepatocyte proliferation independently of liver injury in the mouse

  2004cited by this paper
• The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.

  2003cited by this paper
• NF-κ B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4*

  2003cited by this paper
• Galectin-1 Accumulation in the Ovary Carcinoma Peritumoral Stroma Is Induced by Ovary Carcinoma Cells and Affects Both Cancer Cell Proliferation and Adhesion to Laminin-1 and Fibronectin

  2003cited by this paper
• Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL

  2003cited by this paper
• Galectin-1 induces cell adhesion to the extracellular matrix and apoptosis of non-adherent human colon cancer Colo201 cells.

  2003cited by this paper
• Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.

  2002cited by this paper
• CXCR4/CXCL12 expression and signalling in kidney cancer

  2002cited by this paper
• Galectin‐1 Modulates Human Glioblastoma Cell Migration into the Brain Through Modifications to the Actin Cytoskeleton and Levels of Expression of Small GTPases

  2002cited by this paper
• Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma

  2002cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Negative Regulation of Neuroblastoma Cell Growth by Carbohydrate-dependent Surface Binding of Galectin-1 and Functional Divergence from Galectin-3*

  2001cited by this paper
• Increased expression of galectin‐1 in carcinoma‐associated stroma predicts poor outcome in prostate carcinoma patients

  2001cited by this paper
• Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation

  2001cited by this paper
• Expression of galectin‐1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin‐1 inhibits the growth of 9 glioma cells

  2000cited by this paper
• Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

  1999cited by this paper

• LGALS3BP: A Potential Prognostic Biomarker Influencing Antitumor Immunity in Triple-negative Breast Cancer.

  2025cites this paper
• Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of Cancer

  2025cites this paper
• Intracellular galectin interactions in health and disease

  2024cites this paper
• An Immune‐Regulating Polysaccharide Hybrid Hydrogel with Mild Photothermal Effect and Anti‐Inflammatory for Accelerating Infected Wound Healing

  2024cites this paper
• Differential immunohistochemical expression of Galectin-1 and Galectin-3 in renal cell carcinoma

  2024cites this paper
• Prognostic Influence of Galectin-1 in Gastric Adenocarcinoma

  2024cites this paper
• Galectin-1 binds GRP78 to promote the proliferation and metastasis of gastric cancer

  2022cites this paper
• to promote the proliferation and metastasis of gastric cancer

  2022cites this paper
• The multifaceted role of Matricellular Proteins in health and cancer, as biomarkers and therapeutic targets.

  2022cites this paper
• Bruceine A protects against diabetic kidney disease via inhibiting galectin-1.

  2022cites this paper
• Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma

  2021cites this paper
• Tissue-specific control of galectin-1-driven circuits during inflammatory responses.

  2021cites this paper
• Galectin-1 as a predictive biomarker in ovarian cancer

  2021cites this paper
• MRE11 promotes oral cancer progression through RUNX2/CXCR4/AKT/FOXA2 signaling in a nuclease-independent manner

  2021cites this paper
• Prognostic role of galectins expression in patients with hepatic cancer

  2020cites this paper
• Galectins in the Tumor Microenvironment: Focus on Galectin-1.

  2020cites this paper
• Clinicopathological and prognostic significance of CXCR4 high expression in renal cell carcinoma: a meta-analysis and literature review.

  2019cites this paper
• Galectin-1 Inhibition Induces Cell Apoptosis Through Dual Suppression of CXCR4 and Ras Pathways in Human Malignant Peripheral Nerve Sheath Tumors.

  2019cites this paper
• Human Galectin-1 and its inhibitors: Privileged target for cancer and HIV.

  2019cites this paper
• Pooling analysis reveals that galectin‐1 is a reliable prognostic biomarker in various cancers

  2019cites this paper
• Galectin-1 induces metastasis and epithelial-mesenchymal transition (EMT) in human ovarian cancer cells via activation of the MAPK JNK/p38 signalling pathway.

  2019cites this paper
• Galectin‐3 promotes CXCR2 to augment the stem‐like property of renal cell carcinoma

  2018cites this paper
• Treatment of B-cell precursor acute lymphoblastic leukemia with the Galectin-1 inhibitor PTX008

  2018cites this paper
• Galectins as Molecular Targets for Therapeutic Intervention

  2018cites this paper
• Clinicopathological significance of galectin-1 expression and percentage of galectin-1-expressing T cells in clear-cell renal cell carcinoma.

  2018cites this paper
• Expression of galectin-1 and galectin-3 in renal cell carcinoma; immunohistochemical study.

  2018cites this paper
• Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis

  2018cites this paper
• Galectin-1 in clear cell renal cell carcinoma Clinicopathological significance of galectin-1 expression and percentage of galectin-1-expressing T cells in clear cell renal cell carcinoma

  2018cites this paper
• Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells

  2017cites this paper
• PSC-derived Galectin-1 inducing epithelial-mesenchymal transition of pancreatic ductal adenocarcinoma cells by activating the NF-κB pathway

  2017cites this paper
• Galectin-1 promotes tumor progression via NF-κB signaling pathway in epithelial ovarian cancer

  2017cites this paper
• Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway

  2016cites this paper
• Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling

  2016cites this paper
• Overexpression of galectin-1 indicates poor prognosis in resected non-small cell lung cancer patients

  2016cites this paper
• Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander?

  2016cites this paper
• TNF‐α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma

  2016cites this paper
• Murine Sertoli cells promote the development of tolerogenic dendritic cells: a pivotal role of galectin‐1

  2016cites this paper
• Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis

  2016influential citation
• Clinicopathological significance of CXCR 4 in non-small cell lung cancer

  2015cites this paper
• Globalni proteomski profil ekspresije i uloga proteina IGF2/IGF2R u patogenezi prekanceroznih lezija usne šupljine

  2015cites this paper
• A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer

  2015cites this paper
• Clinicopathological significance of CXCR4 in non-small cell lung cancer

  2015cites this paper
• Clinicopathological Significance of CXCR4 Expression in Renal Cell Carcinoma: A Meta-Analysis

  2015cites this paper
• Studies on the role of goat heart galectin-1 as a tool for detecting post-malignant changes in glycosylation pattern.

  2015cites this paper
• Galectin-8 predicts postoperative recurrence of patients with localized T1 clear cell renal cell carcinoma.

  2015cites this paper
• a meta-analysis for cXcr 4 as a prognostic marker and potential drug target in non-small cell lung cancer

  2015cites this paper
• CXCR4 promotes renal tubular cell survival in male diabetic rats: implications for ligand inactivation in the human kidney.

  2015cites this paper
• Galectins and neovascularization in central nervous system tumors.

  2014cites this paper
• Galectin-1 as a therapeutic target in pancreatic cancer: the tumor stroma in the spotlight

  2014cites this paper
• High CXC chemokine receptor 4 expression is an adverse prognostic factor in patients with clear-cell renal cell carcinoma

  2014cites this paper
• Galectins in cancer: carcinogenesis, diagnosis and therapy.

  2014cites this paper